Egfr;Cas9 mice had slightly lower tumor burden and number than Braf;Cas9 mice and >tenfold fewer tumors than G12D;Cas9 mice (Fig. 3D, E; P = 1.5 × 10−9). Here, BRAF is linked to neoplasm.